These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17585722)

  • 21. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical devices; clinical chemistry and clinical toxicology devices; classification of the breath nitric oxide test system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jul; 68(129):40125-7. PubMed ID: 12858842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(208):61342-4. PubMed ID: 14584507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; ear, nose and throat devices; reclassification of the endolymphatic shunt tube with valve. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Apr; 67(82):20893-4. PubMed ID: 11980454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. User fees and medical device reviews.
    Lewis C
    FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(40):9530-2. PubMed ID: 12617085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceuticals and medical devices: medical devices.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-23. PubMed ID: 19297720
    [No Abstract]   [Full Text] [Related]  

  • 32. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical devices; reclassification of three anesthesiology preamendments class III devices into class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57366-8. PubMed ID: 11776278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11018. PubMed ID: 10557621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical devices; general and plastic surgery devices; classification of the low energy ultrasound wound cleaner. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(214):67353-5. PubMed ID: 16273747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in regulating breakthrough medical devices.
    Muni NI; Gross TP; Boam AB; Wang S; Zuckerman BD
    Food Drug Law J; 2005; 60(2):137-42. PubMed ID: 16097092
    [No Abstract]   [Full Text] [Related]  

  • 37. To have (medical devices) or not: what's safer for patients?
    McCormack J
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract]   [Full Text] [Related]  

  • 38. Cosmetic medical devices and their FDA regulation.
    Newburger AE
    Arch Dermatol; 2006 Feb; 142(2):225-8. PubMed ID: 16490851
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making sense of the food and drug administration.
    Connor JA
    Semin Pediatr Surg; 2006 Nov; 15(4):293-301. PubMed ID: 17055960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.